Operator of a biopharmaceutical company developing micro-environment activated therapeutics. The company offers a drug development pipeline and a clinical biomarker platform to develop drugs which act through pleiotropic mechanisms to inhibit extracellular matrix synthesis and stabilization and to silence activated stromal cells.